Myeloma Minute: IMF Launches Myeloma Action Month


| ACTION | Myeloma Action Month


IMF Launches Myeloma Action Month as of March 1, 2019

This year’s Myeloma Action Month (MAM), beginning March 1, 2019, focuses on Myeloma Warriors. Dr. Brian G.M. Durie, the IMF’s Chairman of the Board, explains that a myeloma warrior is a patient, caregiver, friend, or healthcare provider who has a “broad view about myeloma—not just for yourself, but for others in the myeloma community. This broader view is really the hallmark of a warrior.”

With this in mind, the IMF is asking individuals and groups to spread myeloma awareness on a global scale by using the hashtag #myelomawarrior on all social media channels. When using this hashtag to share stories on Twitter, Facebook, Instagram, and Pinterest, these #myelomawarrior posts will stream to the IMF’s “Wall of Warriors” at the Myeloma Action Month website.

This website also houses shareable graphics that participants can post on their social media channels. Also available on the website is signature Myeloma Warrior-branded merchandise, including T-shirts, sweatshirts, wristbands, and hats. We invite you to explore to learn how you can take actions in your community.


| INNOVATION | Latest Research



What Immune Monitoring Can Tell Us About Myeloma

The Black Swan Research Initiative’s partners in Spain are documenting myriad immune cell patterns in an effort to understand why myeloma progresses—or not. “We already have clues that different subtypes of T cells, NK cells, as well as certain macrophages, are very important in this complex battle,” says IMF Chairman Brian G.M. Durie, MD. What we know for sure is that in this battle, the immune system, he says, can be both friend and foe.


| EDUCATION | Seminar


| EDUCATION | Newsletter


Register Now for a Regional Community Workshop in La Jolla, California
Hot Off the Press: Myeloma Today!

The IMF will host a Regional Community Workshop at the San Diego Marriot (4240 La Jolla Village Dr.) in La Jolla, CA, on Saturday, March 23, 2019. Registration is FREE, but seating is limited. Here’s your chance to learn from and meet one-on-one with myeloma experts Caitlin Costello, MD (UCSD/Sharp Healthcare Transplant Program, San Diego, CA), David H. Vesole, MD, PhD (John Theurer Cancer Center, Hackensack, NJ), and Deborah Doss RN, OCN (Dana-Farber Cancer Institute, Boston, MA).

The Winter edition of Myeloma Today is available free to read or download as a PDF! Read about myeloma highlights from the annual meeting of the American Society of Hematology, the 2019 Brian D. Novis myeloma research grants, the iStopMM research review meeting, and the FDA approval of Empliciti® in combination with Pomalyst® and dexamethasone. Select medical articles are also available in French, German, Italian, and Spanish translations. Visit to sign up for IMF newsletters and e-blasts.

Register Now Button.png


| INSPIRATION | Fundraiser


Register Now for Myeloma Miracles 2019 Walk in Southern California

Two Southern California support groups — the Inland Empire and Inland Valley Warriors — are walking to raise money for the International Myeloma Foundation’s research and education initiatives. If you are in the area, join the First Annual Walk for Myeloma Miracles fundraiser at Central Park (11200 Base Line Rd), in Rancho Cucamonga, California, on March 9, 2019, at 9 a.m. PST. Sign up as an individual or as a team.

Register Now Button.png

| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series



BOSTON Trial Fact Sheet

New isatuximab Clinical Trial: the IMROZ Study

New isatuximab Clinical Trial: the IKEMA Study

Join the conversation about myeloma on the Smart Patients Message Board

March 15-16, 2019
IMF Patient & Family Seminar
Boca Raton, FL

March 23, 2019
Regional Community Workshop
La Jolla, CA

April 5-6, 2019
IMF Patient & Family Seminar
Short Hills, NJ

April 6, 2019
Regional Community Workshop
Seattle, WA

May 11, 2019
Regional Community Workshop
Edina, MN

subscribe_button.png          donate_button_bottom.png
We Thank Our Sponsors:
Amgen, Celgene Corporation, Genentech, Sanofi-Genzyme, and Takeda Oncology
and individuals like you who supported the IMF this year

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.